Gerstein, H C <br/><br/>
Rationale and design of a large study to evaluate the renal and cardiovascular effects of an ACE inhibitor and vitamin E in high-risk patients with diabetes. The MICRO-HOPE Study. Microalbuminuria, cardiovascular, and renal outcomes. Heart Outcomes Prevention Evaluation.  [electronic resource] 

 -  Diabetes care  Nov 1996 
 - 1225-8 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0149-5992 
<br/><br/><label>Standard No.: </label>10.2337/diacare.19.11.1225  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Albuminuria<br/>Angiotensin-Converting Enzyme Inhibitors--therapeutic use<br/>Cardiovascular Diseases--prevention & control<br/>Diabetes Mellitus, Type 1--drug therapy<br/>Diabetes Mellitus, Type 2--drug therapy<br/>Diabetic Angiopathies--prevention & control<br/>Diabetic Nephropathies--epidemiology<br/>Factor Analysis, Statistical<br/>Humans<br/>Middle Aged<br/>Placebos<br/>Ramipril--therapeutic use<br/>Research Design<br/>Risk Factors<br/>Time Factors<br/>Vitamin E--therapeutic use